THE ESCALATING HEALTHCARE CRISIS
By Gregory Spahn
Surging Healthcare Costs
90% of the nation’s $4.5 trillion annual healthcare expenditures go toward chronic and
mental health conditions.
A breakthrough Nitric Oxide (NO) metabolite technology has the potential to revolutionize healthcare and reduce reliance on costly medications and interventions; shifting focus from treatment to prevention.
This novel technology restores NO homeostasis via a patented metabolite and is significantly more effective than other NO generation technologies in several key areas.
Extended Duration of Effectiveness
This NO metabolite remains active in the body for significantly longer than typical NO therapies. Its half-life is approximately 3.5 hours, while remaining effective in the body for over 24 hours. The leading NO based supplements that are currently on the market have a half-life of only 10 minutes and quickly dissipate from the body, therefore limiting any therapeutic effectiveness.
The NO metabolite remains effective in the body for over 24 hours at levels of 8 parts per billion (ppb), while others remain effective for only 8 hours at a negligible level of 0.2 ppb.
Direct NO Delivery
This patented technology does not rely on the body’s ability to synthesize NO from precursors, such as L-arginine or citrulline, thereby offering a more efficient solution, especially for aging individuals.
Versatile Therapeutic Applications
The technology is applicable in various forms (oral capsules, gels, creams, sprays), addressing a range of conditions from cardiovascular health to wound healing.
This superior efficacy in terms of NO release, longevity in the body, and broad applications positions this novel metabolite as a breakthrough in the field of NO therapeutics, with significant advantages over existing solutions.